Imaging AI platform company HOPPR secured nearly $32 million in Series A funding to advance its infrastructure for building and deploying large-scale medical imaging AI models.
Key Details
- 1HOPPR, founded in 2019 and based in Chicago, focuses on AI infrastructure for medical imaging.
- 2The company announced nearly $32 million in Series A funding, led by Greycroft and Kivu Ventures.
- 3Its platform supports PACS vendors and software makers in developing clinical-grade AI applications.
- 4The new funds will accelerate platform development, expand foundation model capabilities, and grow the team.
- 5CEO Khan Siddiqui, MD, states the goal is to democratize access to high-performing, trustworthy imaging AI.
Why It Matters
This funding round enables HOPPR to scale its infrastructure, potentially accelerating the development and deployment of clinically robust AI tools in radiology. Broad access to such platforms could enhance diagnostic workflows, support radiologists, and improve patient care globally.
Source
Radiology Business
Related News
•Radiology Business
FDA Clears Multi-Disease AI Screening Platform for CT Imaging
HeartLung Corporation's AI-CVD platform receives FDA clearance to detect multiple diseases from a single CT scan.
•Cardiovascular Business
FDA Expands Clearance for AI-Guided Echo Exams on Existing Ultrasound Systems
FDA clears UltraSight's AI platform for use with a broader range of existing ultrasound devices, aiding novice users in performing echocardiographic exams.
•Radiology Business
a2z Radiology Raises $5M, Lands FDA Clearance for Multi-Condition CT AI
Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.